Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Suppressor role of activating transcription factor 2 (ATF2) in skin cancer.

Bhoumik A, Fichtman B, Derossi C, Breitwieser W, Kluger HM, Davis S, Subtil A, Meltzer P, Krajewski S, Jones N, Ronai Z.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1674-9. doi: 10.1073/pnas.0706057105. Epub 2008 Jan 28.

2.
3.

Inhibition of CREB function in mouse epidermis reduces papilloma formation.

Rozenberg J, Rishi V, Orosz A, Moitra J, Glick A, Vinson C.

Mol Cancer Res. 2009 May;7(5):654-64. doi: 10.1158/1541-7786.MCR-08-0011. Epub 2009 May 12.

4.

Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.

Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC, Grossman D.

Cancer Res. 2003 Feb 1;63(3):567-72.

5.

Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.

Mustacich D, Wagner A, Williams R, Bair W, Barbercheck L, Stratton SP, Bhattacharyya AK, Powis G.

Carcinogenesis. 2004 Oct;25(10):1983-9. Epub 2004 May 27.

PMID:
15166090
6.
7.

JWA deficiency suppresses dimethylbenz[a]anthracene-phorbol ester induced skin papillomas via inactivation of MAPK pathway in mice.

Gong Z, Shi Y, Zhu Z, Li X, Ye Y, Zhang J, Li A, Li G, Zhou J.

PLoS One. 2012;7(3):e34154. doi: 10.1371/journal.pone.0034154. Epub 2012 Mar 26.

8.

Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.

Chan KS, Sano S, Kataoka K, Abel E, Carbajal S, Beltran L, Clifford J, Peavey M, Shen J, Digiovanni J.

Oncogene. 2008 Feb 14;27(8):1087-94. Epub 2007 Aug 13.

PMID:
17700521
9.

Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.

Hsieh YH, Juliana MM, Hicks PH, Feng G, Elmets C, Liaw L, Chang PL.

Cancer Res. 2006 Jul 15;66(14):7119-27.

10.

Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development.

Formisano P, Perruolo G, Libertini S, Santopietro S, Troncone G, Raciti GA, Oriente F, Portella G, Miele C, Beguinot F.

Oncogene. 2005 Oct 27;24(47):7012-21.

PMID:
16044159
11.

Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.

Kim TW, Porter KL, Foley JF, Maronpot RR, Smart RC.

Mol Carcinog. 1997 Sep;20(1):115-24.

PMID:
9328442
12.

Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.

Rossiter H, Beissert S, Mayer C, Schön MP, Wienrich BG, Tschachler E, Kupper TS.

Cancer Res. 2001 May 1;61(9):3619-26.

13.

The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis.

Virador VM, Flores-Obando RE, Berry A, Patel R, Zakhari J, Lo YC, Strain K, Anders J, Cataisson C, Hansen LA, Yuspa SH.

Mol Carcinog. 2009 Jul;48(7):599-609. doi: 10.1002/mc.20498.

14.

Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.

Kumar R, Alam S, Chaudhari BP, Dwivedi PD, Jain SK, Ansari KM, Das M.

Carcinogenesis. 2013 Mar;34(3):647-57. doi: 10.1093/carcin/bgs368. Epub 2012 Nov 21.

PMID:
23172667
15.

Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.

Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.

Cancer Res. 2001 Feb 1;61(3):970-6.

16.

Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.

La E, Muga SJ, Locniskar MF, Fischer SM.

Mol Carcinog. 1999 Apr;24(4):276-86.

PMID:
10326864
17.

A multihit, multistage model of chemical carcinogenesis.

Owens DM, Wei S, Smart RC.

Carcinogenesis. 1999 Sep;20(9):1837-44.

PMID:
10469632
18.

Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.

Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Medina D, Brinkley BR, Roop DR.

Oncogene. 1998 Jul 9;17(1):35-45.

19.

Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.

Okumura K, Sato M, Saito M, Miura I, Wakana S, Mao JH, Miyasaka Y, Kominami R, Wakabayashi Y.

Carcinogenesis. 2012 Nov;33(11):2260-8. doi: 10.1093/carcin/bgs250. Epub 2012 Jul 28.

PMID:
22843548
20.

Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression.

Stern MC, Gimenez-Conti IB, Budunova I, Coghlan L, Fischer SM, DiGiovanni J, Slaga TJ, Conti CJ.

Carcinogenesis. 1998 Jan;19(1):125-32.

PMID:
9472703

Supplemental Content

Support Center